Browsing by Sponsor/Funder ViiV Healthcare UK Limited
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
|---|---|---|
| 24-Sep-2020 | A randomised feasibility trial of an intervention to support sharing of HIV status for 18-25-year olds living with perinatally acquired HIV compared with standard care: HIV Empowering Adults' Decisions to Share-UK/Uganda Project (HEADS-UP) | Evangeli, M; Foster, C; Musiime, V; Fidler, S; Seeley, J, et al |
| 1-Oct-2021 | Impact of an add-on strategy of the C-C chemokine receptor 5 (CCR5) antagonist maraviroc on hepatic inflammation in HIV-infected individuals with non-alcoholic steatohepatitis: a paired-liver biopsy proof-of-concept study | Ingiliz, P; Maurice, J; Shimakawa, Y; Grunwald, S; Tsochatzis, E, et al |
| 2-Nov-2017 | PD-L1. | Kythreotou, A; Siddique, A; Mauri, FA; Bower, M; Pinato, DJ, et al |
| 14-Aug-2017 | Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: a pilot study | Mletzko, S; Pinato, DJ; Robey, RC; Pria, AD; Benson, P, et al |